BZL101, a phytochemical extract from theScutellaria barbataplant, disrupts proliferation of human breast and prostate cancer cells through distinct mechanisms dependent on the cancer cell phenotype
Publication
, Journal Article
Marconett, CN; Morgenstern, TJ; San Roman, AK; Sundar, SN; Singhal, AK; Firestone, GL
Published in: Cancer Biology & Therapy
August 15, 2010
Duke Scholars
Published In
Cancer Biology & Therapy
DOI
EISSN
1555-8576
ISSN
1538-4047
Publication Date
August 15, 2010
Volume
10
Issue
4
Start / End Page
397 / 405
Publisher
Informa UK Limited
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 3101 Biochemistry and cell biology
- 1112 Oncology and Carcinogenesis
Citation
APA
Chicago
ICMJE
MLA
NLM
Marconett, C. N., Morgenstern, T. J., San Roman, A. K., Sundar, S. N., Singhal, A. K., & Firestone, G. L. (2010). BZL101, a phytochemical extract from theScutellaria barbataplant, disrupts proliferation of human breast and prostate cancer cells through distinct mechanisms dependent on the cancer cell phenotype. Cancer Biology & Therapy, 10(4), 397–405. https://doi.org/10.4161/cbt.10.4.12424
Marconett, Crystal N., Travis J. Morgenstern, Adrianna K. San Roman, Shyam N. Sundar, Ankur K. Singhal, and Gary L. Firestone. “BZL101, a phytochemical extract from theScutellaria barbataplant, disrupts proliferation of human breast and prostate cancer cells through distinct mechanisms dependent on the cancer cell phenotype.” Cancer Biology & Therapy 10, no. 4 (August 15, 2010): 397–405. https://doi.org/10.4161/cbt.10.4.12424.
Marconett CN, Morgenstern TJ, San Roman AK, Sundar SN, Singhal AK, Firestone GL. BZL101, a phytochemical extract from theScutellaria barbataplant, disrupts proliferation of human breast and prostate cancer cells through distinct mechanisms dependent on the cancer cell phenotype. Cancer Biology & Therapy. 2010 Aug 15;10(4):397–405.
Marconett, Crystal N., et al. “BZL101, a phytochemical extract from theScutellaria barbataplant, disrupts proliferation of human breast and prostate cancer cells through distinct mechanisms dependent on the cancer cell phenotype.” Cancer Biology & Therapy, vol. 10, no. 4, Informa UK Limited, Aug. 2010, pp. 397–405. Crossref, doi:10.4161/cbt.10.4.12424.
Marconett CN, Morgenstern TJ, San Roman AK, Sundar SN, Singhal AK, Firestone GL. BZL101, a phytochemical extract from theScutellaria barbataplant, disrupts proliferation of human breast and prostate cancer cells through distinct mechanisms dependent on the cancer cell phenotype. Cancer Biology & Therapy. Informa UK Limited; 2010 Aug 15;10(4):397–405.
Published In
Cancer Biology & Therapy
DOI
EISSN
1555-8576
ISSN
1538-4047
Publication Date
August 15, 2010
Volume
10
Issue
4
Start / End Page
397 / 405
Publisher
Informa UK Limited
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 3101 Biochemistry and cell biology
- 1112 Oncology and Carcinogenesis